News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
808,221 Results
Type
Article (81717)
Company Profile (513)
Press Release (725991)
Multimedia
Podcasts (118)
Webinars (13)
Section
Business (218092)
Career Advice (3752)
Deals (38679)
Drug Delivery (128)
Drug Development (90389)
Employer Resources (183)
FDA (17978)
Job Trends (16688)
News (378343)
Policy (38354)
Tag
Academia (2993)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (55199)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (17944)
Artificial intelligence (303)
Autoimmune disease (28)
Automation (16)
Bankruptcy (388)
Best Places to Work (12520)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (376)
Bladder cancer (85)
Brain cancer (32)
Breast cancer (301)
Cancer (2431)
Cardiovascular disease (204)
Career advice (3195)
Career pathing (34)
CAR-T (173)
Cell therapy (485)
Cervical cancer (21)
Clinical research (72947)
Collaboration (910)
Compensation (551)
Complete response letters (30)
COVID-19 (2864)
CRISPR (48)
C-suite (264)
Cystic fibrosis (107)
Data (2268)
Decentralized trials (2)
Denatured (42)
Depression (56)
Diabetes (296)
Diagnostics (6842)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (142)
Drug pricing (127)
Drug shortages (33)
Duchenne muscular dystrophy (101)
Earnings (85578)
Editorial (44)
Employer branding (23)
Employer resources (158)
Events (125610)
Executive appointments (769)
FDA (19307)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (811)
Gene editing (119)
Generative AI (30)
Gene therapy (356)
GLP-1 (851)
Government (5121)
Grass and pollen (6)
Guidances (67)
Healthcare (20785)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3025)
Inflammatory bowel disease (153)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (729)
IPO (17618)
IRA (51)
Job creations (4637)
Job search strategy (2608)
Kidney cancer (11)
Labor market (37)
Layoffs (552)
Leadership (24)
Legal (9341)
Liver cancer (81)
Lung cancer (345)
Lymphoma (159)
Machine learning (7)
Management (63)
Manufacturing (343)
MASH (75)
Medical device (14496)
Medtech (14501)
Mergers & acquisitions (21618)
Metabolic disorders (784)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (114)
Neuropsychiatric disorders (34)
Neuroscience (2108)
NextGen: Class of 2025 (7556)
Non-profit (5060)
Now hiring (38)
Obesity (423)
Opinion (275)
Ovarian cancer (78)
Pain (99)
Pancreatic cancer (86)
Parkinson's disease (161)
Partnered (22)
Patents (249)
Patient recruitment (116)
Peanut (51)
People (64016)
Pharmaceutical (102)
Pharmacy benefit managers (21)
Phase I (22508)
Phase II (31691)
Phase III (23869)
Pipeline (1255)
Policy (169)
Postmarket research (3494)
Preclinical (10124)
Press Release (72)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (430)
Real estate (7031)
Recruiting (72)
Regulatory (26207)
Reports (43)
Research institute (2648)
Resumes & cover letters (594)
Rett syndrome (5)
RNA editing (5)
RSV (50)
Schizophrenia (81)
Series A (143)
Series B (91)
Service/supplier (15)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (34)
Startups (4097)
State (2)
Stomach cancer (16)
Supply chain (75)
Tariffs (44)
The Weekly (74)
Vaccines (809)
Venture capitalists (44)
Weight loss (303)
Women's health (39)
Worklife (20)
Date
Today (210)
Last 7 days (947)
Last 30 days (2825)
Last 365 days (35175)
2025 (11532)
2024 (37646)
2023 (42367)
2022 (53723)
2021 (58532)
2020 (57454)
2019 (51080)
2018 (38904)
2017 (36538)
2016 (37135)
2015 (43096)
2014 (37405)
2013 (33929)
2012 (35928)
2011 (36031)
2010 (35903)
Location
Africa (1187)
Alabama (60)
Alaska (7)
Arizona (241)
Arkansas (14)
Asia (48269)
Australia (8404)
California (6376)
Canada (2053)
China (561)
Colorado (282)
Connecticut (300)
Delaware (156)
Europe (110270)
Florida (941)
Georgia (213)
Idaho (63)
Illinois (619)
India (29)
Indiana (321)
Iowa (12)
Japan (168)
Kansas (108)
Kentucky (26)
Louisiana (13)
Maine (70)
Maryland (962)
Massachusetts (4903)
Michigan (248)
Minnesota (413)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (26)
Nevada (64)
New Hampshire (70)
New Jersey (1807)
New Mexico (31)
New York (1817)
North Carolina (1108)
North Dakota (9)
Northern California (2746)
Ohio (218)
Oklahoma (15)
Oregon (40)
Pennsylvania (1413)
Puerto Rico (13)
Rhode Island (33)
South America (1559)
South Carolina (24)
South Dakota (1)
Southern California (2374)
Tennessee (102)
Texas (944)
United States (24502)
Utah (190)
Virginia (163)
Washington D.C. (67)
Washington State (593)
West Virginia (3)
Wisconsin (67)
808,221 Results for "tufts center for the study of drug development".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Transneural Therapeutics Appoints CNS Drug Development Expert, Mark A. Demitrack, MD, as Chief Research and Development Officer
April 29, 2025
·
3 min read
Press Releases
Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
December 23, 2024
·
11 min read
Webinar: AI, Regulation and the Law: Shaping the Future of Drug Development
In this discussion, our guests explore how recent regulatory changes are shaping the future of AI in drug development in the US market. Watch now.
April 23, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Boehringer Ingelheim strengthens antibody-drug conjugate portfolio with new NBE Therapeutics R&D center in Basel
April 3, 2025
·
5 min read
IN PARTNERSHIP WITH SMARTLABS
How Modern Vivarium Services Are Revolutionizing Drug Development
In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.
March 24, 2025
·
7 min read
·
BioSpace Insights
BioCapital
Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
60 Degrees Pharmaceuticals, Inc. announced it has entered into an agreement with Tufts Medical Center in Boston to conduct the world’s first clinical trial evaluating the efficacy and safety of tafenoquine in treating human babesiosis patients.
May 30, 2024
·
11 min read
Business
Five Biggest Drug Face-Offs in Pharma History
Wegovy and Zepbound are just the latest drug dyads to face-off in the competitive pharma market, continuing a legacy of rivalry that includes blockbuster drugs Keytruda, Humira and Eliquis.
April 9, 2025
·
9 min read
·
Tristan Manalac
Press Releases
Oligomerix Published Results from a Preclinical Therapeutic Treatment Study on an Oral Experimental Drug in Development for Alzheimer’s and Rare Neurodegenerative Diseases
March 12, 2025
·
3 min read
Policy
C3i Center Inc is First CDMO in Canada to Receive Approval for a Drug Establishment License to Commercially Produce Cell Therapy Drug Products
C3i Center Inc (C3i) announced it has received regulatory approval, in the form of a Drug Establishment License (DEL), to commercially produce cell therapies, making C3i the first CDMO in Canada to achieve this milestone.
June 20, 2024
·
2 min read
Press Releases
Engine Biosciences Appoints Renowned Drug Discovery and Development Leader Robert Abraham, PhD, as Chief Scientific Officer
April 30, 2025
·
3 min read
1 of 80,823
Next
